Finance

Lists
BLTE:NASDAQ
Belite Bio Inc
US$ १५४.४९
+१.२९%
(+१.९७) 1D
US$ १५४.८०
+०.२०% (+०.३१)
Pre-market
Closed: अक्टोबर ९, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLTE...
Open
US$ १५२.७३
High
US$ १५५.९९
Low
US$ १५२.१७
Mkt. cap
६.२२ अरब
Avg. vol.
१.९३ लाख
Volume
३५९.००
52-wk high
US$ २००.००
52-wk low
US$ ७७.६८
EPS
-US$ २.८५
Beta
-१.२३
Shares outstanding
४.०३ करोड
No. of employees
४१
Open
US$ १५२.७३
High
US$ १५५.९९
Low
US$ १५२.१७
Mkt. cap
६.२२ अरब
Avg. vol.
१.९३ लाख
Volume
३५९.००
52-wk high
US$ २००.००
52-wk low
US$ ७७.६८
EPS
-US$ २.८५
Beta
-१.२३
Shares outstanding
४.०३ करोड
No. of employees
४१
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
१ दिन पहिले
(BLTE) Risk Channels and Responsive Allocation
https://www.dars.gov.et/
https://www.dars.gov.et/
·
३ हप्ता पहिले
BLTE Q2 2026 Earnings: Narrower-Than-Expected Loss as Clinical-Stage Pipeline Advances - Earnings Forecast Report
About Belite Bio Inc
CEO-
Employees४१
Founded२०१६
Headquarters-
Sector-
Websitebelitebio.com
Analyst ratings
Based on 7 analysts giving stock ratings to BLTE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current US$ १५४.४९
US$ ३०३.०० (+९६.१३%)
Average
US$ २३६.८६ (+५३.३२%)
Lowest
US$ २००.०० (+२९.४६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
US$ २३४.००
+५१.५%
09/09/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$ २४५.००
+५८.६%
09/09/2026
Whitney Ijem
Canaccord Genuity
Buy
Initiated
US$ ३०३.००
+९६.१%
09/04/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
US$ २००.००
+२९.५%
09/02/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
US$ २०६.००
+३३.३%
08/17/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
US$ २००.००
+२९.५%
08/14/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$ २७०.००
+७४.८%
08/14/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
US$ २१७.००
+४०.५%
03/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.०३ करोड
१.४६ करोड
१.५७ करोड
१.८२ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.२७ करोड
१.३५ करोड
१.७० करोड
१.६७ करोड
Operating expense
२.३० करोड
२.८१ करोड
३.२७ करोड
३.४९ करोड
Total operating expenses
२.३० करोड
२.८१ करोड
३.२७ करोड
३.४९ करोड
Operating income
-२.३० करोड
-२.८१ करोड
-३.२७ करोड
-३.४९ करोड
Other non operating income
-२१.४० लाख
-४.१७ लाख
५७.४६ लाख
६५.५० लाख
EBT including unusual items
-२.१७ करोड
-२.५३ करोड
-२.६९ करोड
-२.८४ करोड
EBT excluding unusual items
-२.१७ करोड
-२.५३ करोड
-२.६९ करोड
-२.८४ करोड
Income tax expense
-
-
-
५५.०० हजार
Effective tax rate
-
-
-
-०.१९%
Other operating expenses
-
-
-
-
Net income
-२.१७ करोड
-२.५३ करोड
-२.६९ करोड
-२.८४ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.६५
-०.७०
-०.६८
-०.७०
Interest and investment income
३४.६८ लाख
३१.७२ लाख
-
-
Interest expense
-
-२.०० हजार
-
-
Net interest expenses
३४.६८ लाख
३१.७० लाख
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.३० करोड
-२.८० करोड
-३.२६ करोड
-३.४९ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू